MedTrace Logo

Effect of Pre-Hospital ARNI Therapy on Short-Term Outcomes in HFrEF

NCT07347925 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 140

Last updated 2026-01-16

No results posted yet for this study

Summary

This study looks at people with heart failure who are admitted to the hospital. The goal of the study is to understand whether taking a heart failure medicine called angiotensin receptor-neprilysin inhibitor (ARNI) before hospital admission affects short-term health outcomes.

The study will compare two groups of participants: those who were already taking ARNI before coming to the hospital and those who were not. Information will be collected from medical records during the hospital stay, including heart-related events, kidney-related events, and how long participants stay in the hospital.

Some participants will also be followed for a short period after discharge. This study may help improve understanding of outcomes associated with ARNI use in people with heart failure in routine clinical care.

Conditions

Interventions

OTHER

Prehospital ARNI use

Participants who were using ARNI therapy before hospital admission

OTHER

No prehospital ARNI use

Participants who were not using ARNI therapy before hospital admission

Sponsors & Collaborators

  • Future University in Egypt

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-10
Primary Completion
2026-04-15
Completion
2026-05-01

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07347925 on ClinicalTrials.gov